Categories
Change Password!
Reset Password!
Short-term nimesulide use demonstrates good tolera...
Effectiveness of PCAB vs. high-dose PPI in refract...
Gastroesophageal reflux disease (GERD) is a chronic ailment marked by the reflux of gastric contents into the esophagus, resulting in persistent...
Taking NSAIDs after 60? Study warns of increased G...
A large hospital-based study from Beijing has identified significant risk factors associated with nonsteroidal anti-inflammatory drug (NSAID)-ind...
Semaglutide shows significant fibrosis improvement...
Metabolic dysfunction associated steatohepatitis (MASH) continues to accelerate fibrosis progression within metabolic dysfunction associated stea...
Long-term intramuscular cyanocobalamin therapy in...
Corpus atrophic gastritis (CAG) is a chronic autoimmune condition characterized by progressive loss of gastric acid secretion and intrinsic facto...
Corticosteroids cut acute kidney injury risk in se...
A new analysis of patients with severe alcohol-associated hepatitis suggests that corticosteroid therapy may noticeably minimize the risk of deve...
First-line antiviral for chronic hepatitis B: Teno...
Chronic hepatitis B (CHB) poses a substantial global health burden requiring effective long-term antiviral therapy.
IBS and lifestyle factors: How stress, sleep, and...
Affecting roughly 10% of people worldwide, irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) condition characterized by persis...
Tegoprazan emerges as fast-acting alternative to P...
A large study has positioned tegoprazan, a potassium-competitive acid blocker (PCAB), as a next-generation therapy for gastroesophageal reflux di...
Low-dose rabeprazole for GI bleeding prevention in...
Antithrombotic therapies escalate the likelihood of upper gastrointestinal (GI) bleeding, particularly in elderly people or those with prior GI e...
